JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirpekar, S. M.
Right arrow Articles by Furchgott, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirpekar, S. M.
Right arrow Articles by Furchgott, R. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 180-190, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


CATECHOLAMINE CONTENT OF THE CAT NICTITATING MEMBRANE FOLLOWING PROCEDURES SENSITIZING IT TO NOREPINEPHRINE

S. M. Kirpekar 1, Peter Cervoni 1, and Robert F. Furchgott 1

1 Department of Pharmacology, State University of New York Downstate Medical Center, Brooklyn, N. Y.

The effect of denervation, decentralization and reserpinization on the catecholamine content (norepinephrine and epinephrine) and sensitivity of the smooth muscles of the nictitating membrane of the cat was Studied. Catecholamine content of superior cervical ganglia was also determined following decentralization and reserpinization.

The predominant catecholamine in nictitating membrane and superior cervical ganglion was norepinephrine. Epinephrine concentration was only a few per cent of that of norepinephrine in both tissues.

A precipitous fall of about 95% in catecholamine content of the nictitating membrane occurred between the twenty-fourth and thirty-sixth hour after removal of time superior cervical ganglion. Two weeks after denervation the content was essentially zero and no recovery was observed up to 105 days. Denervation increased sensitivity of the membrane to exogenous norepinephrine 200- to 300-fold.

Reserpine (1 mg/kg intraperitoneally) reduced norepinephrine content of the nictitating membrane by about 98% within 24 hours after injection and increased sensitivity to norepinephrine only about 2-fold. Essentially full recovery of norepinephrine content was observed 21 days after treatment.

Decentralization did not affect the norepinephrime content of nictitating membranes but increased sensitivity to norepinephrine 10- to 15-fold. Decentralization appeared to increase the norepinephrine content of superior cervical ganglia. Decentralization did not appreciably interfere with either the depletion of catecholamine stores by reserpine in membranes or ganglia, or the time for recovery of such stores following treatment with reserpine.

Certain current hypotheses concerning the cause of supersensitivity in the nictitating membrane are discussed in relation to the data obtained in this study, and none appears to be completely satisfactory. An hypothesis is put forward based on the concept that normal post-ganglionic adrenergic nerve terminals possess a very efficient mechanism for removing norepinephrine, and thus limit the concentration of this substance reaching adrenergic receptors of effector cells. It is proposed that binding of norepinephrine at specific sites is tile initial step in this removal mechanism.

Submitted on July 14, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.